Lsd1 inhibitor treatment in vivo. by Petri Rummukainen (4247122)

Vasodilator capacity to decrease maximal hypoxic mPAP and AUC_SaO2. by Eva Maria Becker (451197)

“…<p>Vasodilator capacity to decrease maximal hypoxic mPAP (positive treatment effect) and AUC_SaO2 (unwanted desaturation effect) based on (A) pooled effects at all dose levels tested (N = 6, four doses per group) and (B) at each drug's maximal effective dose (i.e., cumulative dose) (mean ± SEM, N = 6, doses as indicated). …”

ComBat normalization markedly increases cross-study prediction when the training and test data have varying degrees of overlap in disease-associated OTUs. by Yilin Gao (4335571)

Lsd1 ChIP-seq analysis. by Petri Rummukainen (4247122)

Examples of H3K4 methylation patterns at Lsd1 bound promoters and enhancers visualized by integrative genomic viewer (IGV). by Petri Rummukainen (4247122)

Histone ChIP-seq analysis. by Petri Rummukainen (4247122)

Implications of Nonelectrochemical Reaction Steps on the Oxygen Evolution Reaction: Oxygen Dimer Formation on Perovskite Oxide and Oxynitride Surfaces by Nathalie Vonrüti (5496332)

“…We find that for weakly binding surfaces the *O adsorbate spontaneously adopts a bidentate bridged dimer structure in a nonelectrochemical step with an energy gain in excess of 1 eV. …”

LSD1, Runx1 and Runx2 are expressed abundantly during osteoblast differentiation. by Petri Rummukainen (4247122)

Lsd1 binding correlates with expression status and differential expression. by Petri Rummukainen (4247122)

Lsd1 inhibition in osteoblasts. by Petri Rummukainen (4247122)

Effects of OXA on fasting blood glucose. by Weiran Ye (2552146)

Effects of OXA on body weight gain. by Weiran Ye (2552146)

Schematic illustration of adhesion force measurements on individual monocyte cells using the step-pressure micropipette manipulation technique. by Rita Salánki (649126)

“…<p>a) The tip of the micropipette with an aperture of 5 µm was positioned above the selected cell with a diameter of ∼15 µm cell attached onto the fibrinogen coated surface. …”

Quantifying the Contribution of Statins to the Decline in Population Mean Cholesterol by Socioeconomic Group in England 1991 - 2012: A Modelling Study by Chris Kypridemos (719751)

“…In our ‘no statins’ scenario we predicted a mean total cholesterol of 5.36 mmol/L (95% CI: 5.33-5.40) for 2011-12. …”

Effects of OXA on food intake. by Weiran Ye (2552146)

Effects of OXA on fasting serum insulin levels. by Weiran Ye (2552146)

αENaC and S protein compete for furin-mediated cleavage in a cellular system. by Germán Ricardo Magaña-Ávila (18446799)

Serum VEGF-D levels are elevated at baseline, decrease with sirolimus treatment, and correlate with kidney angiomyolipoma size. by Sandra L. Dabora (206838)

“…According to other studies <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0023379#pone.0023379-Glasgow1" target="_blank">[39]</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0023379#pone.0023379-Young1" target="_blank">[41]</a>, mean serum VEGF-D levels in control female populations are 300–657 ng/ml (indicated by gray box, see additional details in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0023379#pone.0023379.s013" target="_blank">Table S4</a>, mean VEGF-D levels in control males is not available). …”

Effect of cilostazol on the serum ALT (A), AST (B) levels in rats with TAA-induced liver fibrosis. by Sally A. El Awdan (710176)

Effect of cilostazol on liver α-SMA (A) and COL-1 (B) in TAA-induced fibrosis in rats. by Sally A. El Awdan (710176)